Phase I trial of SAR 164653.
Latest Information Update: 15 Nov 2011
At a glance
- Drugs SAR 164653 (Primary)
- Indications Cardiovascular disorders; Diabetic angiopathies
- Focus Adverse reactions
- 15 Nov 2011 New trial record
Latest Information Update: 15 Nov 2011